https://www.selleckchem.com/products/GDC-0941.html
The incorporation of immune checkpoint inhibitors in the oncologists' arsenal is a milestone in cancer therapeutics, though not being devoid of toxicities.Areas covered The present review provides a comprehensive and up-to-date overview of the immune-related hypophysitis with focus on the elusive biological background, the wide spectrum of the epidemiological profile, the varying clinical aspects, and the diagnostic and therapeutic challenges.Expert opinion Historically considered distinctive of anti-cytotoxic T-lymphocyte antigen 4 (C
Like
Comment
Share
